How do people with rheumatoid arthritis experience participation in a smoking cessation trial: a qualitative study
- PMID: 32046611
- PMCID: PMC7034478
- DOI: 10.1080/17482631.2020.1725997
How do people with rheumatoid arthritis experience participation in a smoking cessation trial: a qualitative study
Abstract
Purpose: The aim of this study was to gain more knowledge on how people with rheumatoid arthritis (RA) experienced participation in a randomized controlled trial (RCT) testing the effect of a smoking cessation intervention since this intervention have not been tested on an RA population beforeMethods: We conducted a qualitative study with semi-structured individual interviews with 12 participants from the intervention group in the RCT.Results: Through thematic analysis we identified four themes: Instilling hope for smoking cessation, referring to the initial invitation to participate in the RCT; Various components of importance in the intervention, referring to cooperation with the smoking cessation counsellor, improved carbon monoxide levels, fear of becoming addicted to nicotine replacement therapy, and suggestions for additional components in the intervention which could promote motivation; Breaking habits, referring to ongoing reflection on quitting smoking; and Increased awareness of health, arthritis and smoking, referring to the lack of information on smoking and RA from health professionals, and the impact of smoking on RA symptoms and overall health.Conclusion: The results reflect the participants' perspective on what is meaningful to them when trying to quit smoking and adds important knowledge to future smoking cessation studies in this patient group.
Keywords: Smoking cessation; behaviour change; nicotine replacement therapy; qualitative research; rheumatoid arthritis; smoking; smoking cessation intervention.
Conflict of interest statement
Ida Kristiane Roelsgaard, Thordis Thomsen and Lena Andersen declare no conflicts of interests. Mikkel Østergaard has received research support, consultancy fees and/or speaker fees from Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB. Anne Grete Semb has received speaker honoraria and/or consulting fee from KPMG, Novartis, Bayer and AbbVie. Anne Grete Semb has a collaborative agreement for independent research from Eli Lilly related to the ATACC-RA. Eli Lilly has no role in study design, data collection and analysis, decision to publish, or preparation of manuscripts. Bente Appel Esbensen has received speaking fees from Pfizer and Eli Lilly.
Similar articles
-
Exploring perceptions of a rheumatoid arthritis-specific smoking cessation programme.Musculoskeletal Care. 2018 Mar;16(1):74-81. doi: 10.1002/msc.1209. Epub 2017 Jul 6. Musculoskeletal Care. 2018. PMID: 28681572 Clinical Trial.
-
Reconceptualizing motivation for smoking cessation among people with rheumatoid arthritis as incentives and facilitators.Musculoskeletal Care. 2018 Mar;16(1):139-146. doi: 10.1002/msc.1227. Epub 2017 Dec 13. Musculoskeletal Care. 2018. PMID: 29235264
-
The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial.Trials. 2017 Nov 28;18(1):570. doi: 10.1186/s13063-017-2309-5. Trials. 2017. PMID: 29183347 Free PMC article. Clinical Trial.
-
Identifying barriers to smoking cessation in rheumatoid arthritis.Arthritis Care Res (Hoboken). 2015 May;67(5):607-15. doi: 10.1002/acr.22503. Arthritis Care Res (Hoboken). 2015. PMID: 25370172
-
Developing a Tailored Smoking Cessation Intervention for Rheumatoid Arthritis Patients.Musculoskeletal Care. 2016 Mar;14(1):2-14. doi: 10.1002/msc.1106. Epub 2015 May 18. Musculoskeletal Care. 2016. PMID: 25982887 Clinical Trial.
Cited by
-
A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis.PLoS One. 2022 Dec 15;17(12):e0279065. doi: 10.1371/journal.pone.0279065. eCollection 2022. PLoS One. 2022. PMID: 36520847 Free PMC article.
-
I smoke to cope with pain: patients' perspectives on the link between cigarette smoking and pain.Wien Klin Wochenschr. 2021 Oct;133(19-20):1012-1019. doi: 10.1007/s00508-021-01931-x. Epub 2021 Aug 30. Wien Klin Wochenschr. 2021. PMID: 34460005
References
-
- Abhishek, A., Butt, S., Gadsby, K., Zhang, W., & Deighton, C. M. (2010). Anti-TNF-alpha agents are less effective for the treatment of rheumatoid arthritis in current smokers. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases, 16(1), 15–9. - PubMed
-
- Aimer, P., Stamp, L., Stebbings, S., Valentino, N., Cameron, V., & Treharne, G. J. (2015). Identifying barriers to smoking cessation in rheumatoid arthritis. Arthritis Care & Research, 67(5), 607–615. - PubMed
-
- Aimer, P., Stamp, L. K., Stebbings, S., Cameron, V., Kirby, S., & Treharne, G. J. (2018). Exploring perceptions of a rheumatoid arthritis-specific smoking cessation programme. Musculoskeletal Care, 16(1), 74–81. - PubMed
-
- Aimer, P., Treharne, G. J., Stebbings, S., Frampton, C., Cameron, V., Kirby, S., & Stamp, L. K. (2017). Efficacy of a rheumatoid arthritis-specific smoking cessation program: A randomized controlled pilot trial. Arthritis Care & Research, 69(1), 28–37. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical